Anaphylaxis (with respiratory involvement)

1. Comprehensive Introduction & Overview

Anaphylaxis is a severe, life-threatening, systemic hypersensitivity reaction characterized by a rapid onset of airway, breathing, or circulatory problems. When respiratory involvement is present, the clinical picture is defined by upper airway obstruction (laryngeal edema) and/or lower airway bronchospasm, often accompanied by hypoxemia.

As a medical emergency, anaphylaxis requires immediate recognition and pharmacological intervention. Unlike milder allergic reactions, anaphylaxis represents a multi-system failure triggered by the massive release of inflammatory mediators from mast cells and basophils. The "respiratory involvement" sub-category is particularly critical, as it is the leading cause of mortality in anaphylactic events due to rapid asphyxiation.

Clinical Definition

Anaphylaxis is clinically diagnosed when any of the following three criteria are met:
1. Acute onset of an illness (minutes to hours) involving the skin, mucosal tissue, or both, AND at least one of the following:
* Respiratory compromise (e.g., dyspnea, wheeze, stridor, hypoxemia).
* Reduced blood pressure or associated symptoms of end-organ dysfunction (e.g., hypotonia, syncope).
2. Two or more of the following that occur rapidly after exposure to a likely allergen:
* Skin/mucosal involvement.
* Respiratory compromise.
* Reduced blood pressure.
* Persistent gastrointestinal symptoms.
3. Reduced blood pressure after exposure to a known allergen.

2. Pathophysiology and Mechanisms

The underlying mechanism of anaphylaxis is an IgE-mediated type I hypersensitivity reaction, although non-IgE-mediated (anaphylactoid) pathways also exist.

The Cascade

1. Sensitization: Initial exposure to an antigen leads to the production of allergen-specific IgE, which binds to high-affinity receptors (FcεRI) on the surface of mast cells and basophils.
2. Re-exposure: Upon re-exposure, the allergen cross-links the IgE antibodies, triggering degranulation.
3. Mediator Release:
4. Histamine: Causes vasodilation, increased capillary permeability, and smooth muscle contraction (bronchospasm).
5. Tryptase: Leads to tissue destruction and activation of the complement and coagulation cascades.
6. Leukotrienes (C4, D4, E4): Potent bronchoconstrictors; significantly more potent than histamine in inducing respiratory distress.
7. Prostaglandin D2: Contributes to vasodilation and bronchoconstriction.

Respiratory Impact

• Upper Airway: Laryngeal edema, caused by increased vascular permeability in the glottic and subglottic tissues, leads to stridor and potential total airway occlusion.
• Lower Airway: Bronchoconstriction, mucosal edema, and mucus hypersecretion lead to wheezing, air trapping, and ventilation-perfusion (V/Q) mismatch.

3. Clinical Staging and Grading

To manage anaphylaxis effectively, clinicians utilize severity grading scales to determine the intensity of intervention required.

4. Standard Presentation and Differential Diagnosis

Standard Presentation

The onset is typically sudden, often occurring within 5 to 30 minutes of exposure.
* Respiratory: Sensation of "throat closing," hoarseness, stridor (upper airway), wheezing (lower airway), tachypnea, and cyanosis.
* Cutaneous: Generalized flushing, urticaria, or angioedema (though 10-20% of cases may lack skin involvement).
* Cardiovascular: Tachycardia, hypotension, or palpitations.

Differential Diagnosis

It is imperative to differentiate anaphylaxis from other conditions that mimic respiratory distress:
* Asthma Exacerbation: Usually lacks cutaneous/GI symptoms or hypotension.
* Vasovagal Syncope: Characterized by bradycardia (not tachycardia) and lack of respiratory distress.
* Panic Attack: Absence of clinical markers (wheeze, hypotension, hives).
* Foreign Body Aspiration: Sudden onset of stridor without systemic symptoms.
* Hereditary Angioedema: Lack of urticaria; history of recurrent episodes.

5. Key Diagnostic Tests and Clinical Assessment

Diagnostic confirmation is often retrospective, as treatment must be initiated empirically.

1. Serum Tryptase: The gold standard for biochemical confirmation. Should be drawn 1-2 hours after onset and again at 24 hours. A rise in levels confirms mast cell degranulation.
2. Pulse Oximetry: Essential for monitoring oxygen saturation.
3. Arterial Blood Gas (ABG): Utilized in severe cases to assess for hypercapnia (respiratory failure) and acidosis.
4. Bedside Ultrasonography: Useful for assessing glottic edema and cardiac contractility.

6. Risks, Side Effects, and Contraindications

Management Risks

• Epinephrine Overdose: Can cause myocardial ischemia or arrhythmias, particularly in elderly patients with pre-existing coronary artery disease.
• Refractory Anaphylaxis: Failure to respond to initial epinephrine doses, requiring IV infusion or glucagon.

Contraindications

• Absolute: There are no absolute contraindications to the use of intramuscular epinephrine in the setting of anaphylaxis.
• Relative: In patients with severe hypertension or ischemic heart disease, the benefit of epinephrine still outweighs the risk of cardiac events due to the high mortality rate of untreated anaphylaxis.

7. Clinical Management Protocol

1. Epinephrine: The first-line therapy. Administered intramuscularly (IM) into the mid-outer thigh (vastus lateralis). Adult dose: 0.3–0.5 mg (1:1000 concentration).
2. Positioning: Patient should be placed in a supine position with legs elevated (unless there is severe respiratory distress, in which case they may be placed in a position of comfort).
3. Oxygen Therapy: High-flow oxygen via non-rebreather mask.
4. Adjunctive Medications:
5. H1/H2 Antihistamines: For cutaneous symptoms (do not treat respiratory symptoms).
6. Corticosteroids: To prevent the "biphasic" reaction (delayed recurrence).
7. Beta-2 Agonists (Albuterol): Specifically for persistent bronchospasm.

8. Frequently Asked Questions (FAQ)

1. What is the most important intervention for anaphylaxis?

Epinephrine is the only life-saving intervention. Delaying epinephrine is the most common cause of fatality.

2. Why is epinephrine given in the thigh?

The mid-outer thigh (vastus lateralis) provides the fastest absorption rate compared to subcutaneous or deltoid injection.

3. What is a biphasic reaction?

It is the recurrence of symptoms after the initial resolution, despite no further exposure to the allergen. It occurs in 5-20% of patients.

4. Are antihistamines enough to stop anaphylaxis?

No. Antihistamines do not prevent or treat airway obstruction or hypotension. They only target histamine-mediated skin symptoms.

5. How long should a patient be observed?

For mild cases, 4-6 hours. For severe cases with respiratory or cardiovascular compromise, 12-24 hours.

6. Can I use an inhaler instead of an epinephrine pen?

No. Albuterol only targets bronchospasm; it does not treat laryngeal edema or hypotension.

7. What if the patient is on beta-blockers?

Patients on beta-blockers may be resistant to epinephrine. Glucagon may be required as an alternative agent to support blood pressure.

8. Does the patient need an allergy referral?

Yes. Every patient who experiences anaphylaxis must be referred to an allergist for skin testing or specific IgE blood tests.

9. Is there any way to prevent future episodes?

Strict allergen avoidance and carrying two epinephrine autoinjectors at all times are the cornerstones of prevention.

10. What is the prognosis?

With prompt recognition and treatment, the prognosis is excellent. Mortality is almost exclusively linked to delayed administration of epinephrine.

9. Long-term Prognosis and Management

The long-term management of patients with a history of anaphylaxis focuses on education and preparation.

• Action Plans: Patients must possess a written Anaphylaxis Emergency Action Plan.
• Medical Identification: Wearing a medical alert bracelet is mandatory to inform emergency responders of the allergy.
• Psychological Support: Anaphylaxis is a traumatic event. Patients often develop "food anxiety" or post-traumatic stress symptoms, which should be addressed via counseling.
• Prognostic Outlook: With proper avoidance strategies, patients lead normal lives. However, the presence of comorbid asthma significantly increases the risk of severe, fatal respiratory outcomes during subsequent episodes.

10. Summary for Clinicians

Anaphylaxis with respiratory involvement is a medical emergency that demands rapid clinical intuition. By prioritizing the intramuscular administration of epinephrine and maintaining a high index of suspicion for airway compromise, clinicians can mitigate the mortality risk. Always assume the worst-case scenario (airway obstruction) and prepare for early intubation if the patient exhibits signs of vocal cord edema or profound hypoxemia. Constant monitoring, serial assessment, and patient education remain the pillars of successful clinical management.

Related Clinical Integration

In the acute management of anaphylaxis with respiratory involvement, rapid pharmacological intervention is paramount; clinicians must prioritize the immediate administration of Epinephrine / إبينفرين 1mg/10ml to stabilize airway patency and hemodynamic status, followed by adjunctive therapy with Antihistamines (e.g., Diphenhydramine - for contrast reaction management) / مضادات الهيستامين (مثل ديفينهيدرامين - لإدارة تفاعلات التباين) Standard to mitigate secondary allergic manifestations. Beyond immediate resuscitation, maintaining clinical proficiency in systemic emergencies is critical, as evidenced by the diagnostic parallels found in Conquering Bishmushc SIRS Sepsis: A Doctor's Exam Prep and the structured approach to trauma and shock outlined in ATLS Protocol: Pelvic Fracture Workup & Management Explained. Furthermore, for practitioners seeking to maintain broad clinical competency, these acute care principles are reinforced through comprehensive study resources, including Orthopedic Review | Dr Hutaif General Orthopedics Revie -..., Orthopedic Trauma Review | Dr Hutaif Trauma & Fractures -..., and Orthopedics Hyperguide Review | Dr Hutaif General Ortho -..., which collectively ensure that hospital staff remain prepared for the complex intersection of